- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| APOTEX HEALTH Aktie jetzt für 0€ handeln | |||||
| 13:19 | Apotex reports $38M net loss in first quarter after going public in June | 1 | BNN Bloomberg | ||
| 11:59 | Apotex Health Corp.: Apotex Announces First Quarter 2027 Results | 114 | PR Newswire | - Canada Delivers 11% Revenue Growth in Q1
- Adjusted EBITDA1 of $259 Million with 31% Margin
- Launch Momentum Supports FY 2027 Guidance: Upper Mid-Single Digit... ► Artikel lesen | |
| 17.07. | Apotex Health Corp: Apotex rated as investment-grade issuer by Morningstar | 1 | Stockwatch | ||
| 16.07. | Apotex secures investment grade rating, amends credit facility | 1 | Investing.com | ||
| 16.07. | Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement | 1 | CNW | ||
| 16.07. | Apotex erhält Investment-Grade-Rating und sichert sich verbesserte Kreditkonditionen | 1 | Investing.com Deutsch | ||
| 10.07. | Apotex Health Corp: Apotex Health to release Q1 2027 results on Aug. 12 | 1 | Stockwatch | ||
| 09.07. | Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026 | 2 | CNW | ||
| 09.07. | Apotex Health Corp: Apotex launches four generic Infuvite products in U.S. | 1 | Stockwatch | ||
| 08.07. | Apotex expands U.S. hospital portfolio with launch of generic Infuvite Adult and Pediatric Injection | 1 | CNW | ||
| 02.07. | Weekly Buzz: Vertex Pharmaceuticals, Apotex Health Gain FDA Nod; Unicycive Therapeutics Disappoints; Ipsen Opens Wallet; Vistagen Therapeutics Misses Goal | 1.009 | AFX News | BASEL (dpa-AFX) - The holiday-shortened week delivered no shortage of action for the biotech sector, with a mix of FDA, China, Canada, and EU approvals, acquisitions, and positive clinical readouts... ► Artikel lesen | |
| 02.07. | Apotex Completes Strategic Transaction With Cumberland Pharmaceuticals | 4 | pulse2.com | ||
| 01.07. | Apotex Inc.: Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals | 216 | PR Newswire | TORONTO, July 1, 2026 /PRNewswire/ - Apotex Health Corp. ("Apotex") (TSX: APTX), the largest Canadian-based pharmaceutical company, today announced the closing... ► Artikel lesen | |
| 01.07. | Apotex Health Corp: Apotex Health receives Health Canada OK for Sevmia | 1 | Stockwatch | ||
| 30.06. | Apotex first to receive Health Canada approval for SEVMIA, a generic semaglutide for chronic weight management | 2 | CNW | ||
| 17.06. | Apotex Health Corp: Apotex Health closes $1.49-million public offering | 2 | Stockwatch | ||
| 16.06. | Apotex CEO says IPO provides greater growth potential, despite more scrutiny | 1 | BNN Bloomberg | ||
| 16.06. | Apotex Health Corp. Announces Closing Of Upsized Initial Public Offering And Exercise Of Over-allotment Option In Full | 1 | CNW | ||
| 11.06. | Toronto Stock Exchange: Apotex Health Corp. (APTX) Opens the Market | 449 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 11, 2026) - Jeff Watson, President and Chief Executive Officer, Apotex Health Corp. (Apotex) (TSX: APTX) along with its Board of Directors, executive team... ► Artikel lesen | |
| 10.06. | Apotex Health completes largest life sciences IPO in TSX history | 2 | The Market Online Canada |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,800 | -0,31 % | 2. Quartal 2026: Bayer ist operativ auf Kurs und macht entscheidende Fortschritte | Der Bayer-Konzern ist auch im 2. Quartal 2026 weiter vorangekommen und verzeichnet damit ein erfolgreiches 1. Halbjahr. "Operativ sind wir auf einem guten Weg, unsere Jahresziele zu erreichen", sagte... ► Artikel lesen | |
| NOVO NORDISK | 39,905 | -2,60 % | Ihre wichtigsten Termine: Frische Zahlen von Ebay, Eli Lill, Allstate, Infineon, Novo Nordisk, Walt Disney | Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 06:45 Uhr, Deutschland: Basler... ► Artikel lesen | |
| SCHOTT PHARMA | 21,900 | -2,23 % | Ihre wichtigsten Termine: Tui, Bechtle, Jenoptik, Douglas, Eon und Freenet mit frischen Zahlen-Updates | © Foto: Clara Margais/dpa/dpa-tmnGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| BACHEM | 78,40 | -1,45 % | Bachem Holding AG H1 Sales Increase | HONG KONG (dpa-AFX) - Bachem Holding AG (BHM.F) announced earnings for first half of CHF50.3 million.The company's earnings came in at CHF50.3 million, or CHF0.67 per share. This compares with... ► Artikel lesen | |
| DR REDDYS | 10,700 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ALMIRALL | 10,660 | -0,56 % | Almirall, S.A.: Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology | The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall's expertise in skin science to jointly advance an innovative small-molecule program in... ► Artikel lesen | |
| POLYPEPTIDE GROUP | 46,800 | -0,11 % | Aktien Schweiz schwächer - Polypeptide-Aktie mit Gebot gesucht | DJ Aktien Schweiz schwächer - Polypeptide-Aktie mit Gebot gesucht
DOW JONES--Mit einem Minus hat der schweizerische Aktienmarkt den ersten Handelstag der Woche beendet. Die sich weiter zuspitzende... ► Artikel lesen | |
| MERCK KGAA | 138,85 | -0,82 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Rheinmetall, Deutsche Telekom, Siemens, Airbnb & Lyft | © Foto: Julian Stratenschulte/dpa Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,390 | -0,45 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Successfully completed human factors validation study and pharmacokinetic study for Anaphylm (dibutepinephrine) sublingual filmRemains on track to resubmit Anaphylm NDA to the FDA in Q3 2026Continues... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 42,010 | -0,10 % | Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 | ASN-001 targets the substantially larger population of moderate infantile hemangiomas currently treated off-label with topical timololComplementary product to HEMANGEOL (propranolol hydrochloride)... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 80,46 | +0,26 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| LB PHARMACEUTICALS | 45,290 | -0,09 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027 Announced plans for pipeline expansion of LB-102 into... ► Artikel lesen | |
| KARDIGAN | 22,120 | +0,27 % | Kardigan, Inc. - 10-Q, Quarterly Report | ||
| GENERATE BIOMEDICINES | 14,280 | +0,07 % | Generate Biomedicines, Inc. - 10-Q, Quarterly Report | ||
| APNIMED | 24,680 | -0,76 % | Apnimed, Inc.: Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) ("Apnimed"), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization... ► Artikel lesen |
APOTEX HEALTH CORP gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu APOTEX HEALTH CORP finden Sie auf Wallstreet Online.